Live
- ‘Get Set, Grow Summit 2024’ Focuses on Digital Detox for Families
- Stokes motivates his team to put in extra effort, says England pacer Potts
- From overcoming setbacks to leading India in U19 Women’s Asia Cup, Niki Prasad's amazing journey
- Driving Enterprise Security: Inside Venkata Reddy Thummala’s Leadership Journey
- Constitution debate: PM Modi hails 'Nari Shakti'; makes strong pitch for 'United Bharat’
- Abhijeet Bhardwaj: Revolutionizing Enterprise Analytics with Innovation and Expertise
- Bihar: Inquiry initiated against principal who went to buy veggies during school hours
- Press Sri Lankan Prez for release of Indian fishermen: TN Cong MP to EAM Jaishankar
- TN: DMK postpones executive meet due to heavy rains & Parliament session
- Porous silicon oxide electrodes can fix durability issues in batteries: Researchers
Protein research opens potential treatment of Alzheimers
In a potential breakthrough in treatment of Alzheimer\'s disease, researchers have discovered that a protein can reverse the devastating disease projected to affect nearly 65 million people globally by 2030. The study was led by scientists at the University of Glasgow (UG) and the Hong Kong University of Science and Technology (HKUST).
London: In a potential breakthrough in treatment of Alzheimer's disease, researchers have discovered that a protein can reverse the devastating disease projected to affect nearly 65 million people globally by 2030. The study was led by scientists at the University of Glasgow (UG) and the Hong Kong University of Science and Technology (HKUST).
The research, published in Proceedings of the National Academy of Sciences USA (PNAS), was co-led by Professor Eddy Liew from the UG's Institute of Infection, Immunity and Inflammation and Professor Nancy Ip of HKUST.
The study has discovered that a protein called IL-33 can reverse Alzheimer's disease like pathology and cognitive decline in mice. Alzheimer's disease is a devastating condition with no known effective treatment.
It is the most common cause of dementia, affecting around 850,000 people in the UK, mainly over the age of 65. It affects 1/14 people in this age group and is increasing with the ageing population.
Globally, 65 million people are projected to develop Alzheimer's by 2030. Professor Eddy Liew, Fellow of the Royal Society, who co- directed the research said, "Alzheimer's disease currently has an urgent unmet clinical need.
